LataMed AI is trading 46% down at $0.38 amid a sharp selloff, with no fresh company-specific news, filings, or regulatory actions explaining the move.
- The decline appears driven by heightened volatility and profit-taking following recent price spikes rather than a defined fundamental event.
- The stock's thinly traded OTC profile and broader risk sentiment are likely contributing to the downward pressure in the absence of new disclosures.